Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 209819
Company: INDIVIOR
Company: INDIVIOR
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SUBLOCADE | BUPRENORPHINE | 100MG/0.5ML (100MG/0.5ML) | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | Prescription | None | Yes | No |
SUBLOCADE | BUPRENORPHINE | 300MG/1.5ML (200MG/ML) | SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/30/2017 | ORIG-1 | Approval | Type 3 - New Dosage Form | PRIORITY; Orphan |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209819s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209819Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209819Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2017/209819Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/19/2024 | SUPPL-29 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/209819Orig1s029ltr.pdf |
12/15/2023 | SUPPL-28 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209819Orig1s028ltr.pdf | |
09/12/2023 | SUPPL-26 | Manufacturing (CMC)-Expiration Date |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819Orig1s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209819Orig1s026ltr.pdf | |
07/03/2023 | SUPPL-24 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209819Orig1s024ltr.pdf |
03/13/2023 | SUPPL-22 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209819Orig1s022ltr.pdf | |
01/06/2023 | SUPPL-21 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209819Orig1s021ltr.pdf |
06/17/2022 | SUPPL-20 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209819s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/209819Orig1s020ltr.pdf | |
09/22/2021 | SUPPL-19 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209819Orig1s019ltr.pdf |
06/17/2021 | SUPPL-18 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209819Orig1s018ltr.pdf | |
03/04/2021 | SUPPL-17 | Labeling-Package Insert |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s017s018lbl.pdf | |
06/15/2020 | SUPPL-16 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209819Orig1s016ltr.pdf |
05/11/2021 | SUPPL-15 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209819Orig1s015ltr.pdf | |
02/04/2020 | SUPPL-12 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209819s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209819Orig1s012ltr.pdf | |
08/23/2022 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209819s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/209819Orig1s010ltr.pdf | |
10/07/2019 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209819s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/209819Orig1s009ltr.pdf | |
03/05/2018 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209819s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/209819Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/15/2023 | SUPPL-28 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819s028lbl.pdf | |
09/12/2023 | SUPPL-26 | Manufacturing (CMC)-Expiration Date | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819Orig1s026lbl.pdf | |
03/13/2023 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209819s022lbl.pdf | |
08/23/2022 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209819s010lbl.pdf | |
06/17/2022 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209819s020lbl.pdf | |
06/17/2021 | SUPPL-18 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf | |
05/11/2021 | SUPPL-15 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s015lbl.pdf | |
03/04/2021 | SUPPL-17 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s017s018lbl.pdf | |
02/04/2020 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209819s012lbl.pdf | |
10/07/2019 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209819s009lbl.pdf | |
03/05/2018 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209819s001lbl.pdf | |
11/30/2017 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209819s000lbl.pdf |